Treace Medical Concepts, Inc. (TMCI) Stock

Healthcare · Medical Devices · Member of Other US Stocks

Treace Medical Concepts, Inc. (TMCI) closed at USD 4.04 on 2026-10-14, a change of -40.9 % over the past year, with a market capitalization of USD 267.94M.

Treace Medical Concepts, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Treace Medical Concepts, Inc. key figures

Previous close

USD 4.04 (2026-10-14)

1-year change

-40.9 %

Market cap

USD 267.94M

Enterprise value

USD 295.37M

P/E ratio (trailing)

-4.48

P/E ratio (forward)

-4.85

EPS (trailing)

-0.92

EPS (forward)

-0.85

PEG ratio

n/a

Price to book

3.95

Revenue growth

-4.2 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

8.87

Employees

450

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Treace Medical Concepts, Inc.

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant. In addition, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction. Further, it provides FastGrafter Autografter Harvesting System; SpeedRelease Guided Release Instrument; TriTome Triple-Edge Release Instrument; RazorTome 7mm Precision Osteotome; LapiTome Hooked Bone Removal Osteotome; GreatRelease Rapid MTP Release Instrument; CornerChisel Release Tool; NanoRasp MIS Bone Contouring Tool; FeatherRasp Rapid Bone Contouring Instrument; and Akinator Single-cut Akin Wedge Osteotomy tool. Additionally, the company offers biologics and wedges, such as Treace Allograft Wedges; and CortiFuse Flowable Cortical Fibers. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Treace Medical Concepts, Inc. and compare it with other stocks.